智通财经网·2026-03-30 12:48Core Viewpoint - Tiger Medical (03347) reported a revenue of 6.833 billion yuan for the year ending December 31, 2025, representing a year-on-year increase of 3.48% [1] Financial Performance - The net profit attributable to shareholders reached 888 million yuan, marking a significant year-on-year increase of 119.15% [1] - Basic earnings per share were reported at 1.04 yuan, with a proposed cash dividend of 1.26 yuan for every 10 shares to all shareholders [1] Segment Performance - Revenue from the clinical trial technology services segment was 3.267 billion yuan, up from 3.178 billion yuan in the same period last year [1] - Revenue from clinical trial-related services and laboratory services increased by 4.1% year-on-year, rising from 3.425 billion yuan to 3.566 billion yuan [1]